NDFOS Co. Ltd - Asset Resilience Ratio
NDFOS Co. Ltd (238090) has an Asset Resilience Ratio of 4.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how NDFOS Co. Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of NDFOS Co. Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down NDFOS Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 238090 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩5.08 Billion | 4.56% |
| Total Liquid Assets | ₩5.08 Billion | 4.56% |
Asset Resilience Insights
- Limited Liquidity: NDFOS Co. Ltd maintains only 4.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
NDFOS Co. Ltd Industry Peers by Asset Resilience Ratio
Compare NDFOS Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cngr Advanced Material Co Ltd
SHE:300919 |
Specialty Chemicals | 0.52% |
|
Luxi Chemical Group Co Ltd
SHE:000830 |
Specialty Chemicals | 0.43% |
|
Guangdong HongDa Blasting Co Ltd
SHE:002683 |
Specialty Chemicals | 1.05% |
|
Lily Group Co Ltd
SHG:603823 |
Specialty Chemicals | 0.37% |
|
Lianhe Chemical Technology Co Ltd
SHE:002250 |
Specialty Chemicals | 0.44% |
|
Shandong Link Science and Technology Co Ltd
SHE:001207 |
Specialty Chemicals | 18.99% |
|
Shenzhen WOTE Advanced Materials Co Ltd
SHE:002886 |
Specialty Chemicals | 3.77% |
|
New East New Materials Co Ltd
SHG:603110 |
Specialty Chemicals | 6.08% |
Annual Asset Resilience Ratio for NDFOS Co. Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for NDFOS Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 24.80% | ₩26.26 Billion ≈ $17.80 Million |
₩105.88 Billion ≈ $71.75 Million |
-6.95pp |
| 2023-12-31 | 31.76% | ₩44.82 Billion ≈ $30.37 Million |
₩141.12 Billion ≈ $95.64 Million |
-4.71pp |
| 2022-12-31 | 36.47% | ₩63.09 Billion ≈ $42.76 Million |
₩173.01 Billion ≈ $117.24 Million |
-18.17pp |
| 2021-12-31 | 54.63% | ₩126.69 Billion ≈ $85.86 Million |
₩231.90 Billion ≈ $157.15 Million |
+13.58pp |
| 2020-12-31 | 41.05% | ₩71.73 Billion ≈ $48.61 Million |
₩174.72 Billion ≈ $118.41 Million |
+5.67pp |
| 2019-12-31 | 35.38% | ₩67.20 Billion ≈ $45.54 Million |
₩189.92 Billion ≈ $128.71 Million |
+1.34pp |
| 2018-12-31 | 34.04% | ₩44.38 Billion ≈ $30.08 Million |
₩130.37 Billion ≈ $88.35 Million |
+3.60pp |
| 2017-12-31 | 30.44% | ₩28.23 Billion ≈ $19.13 Million |
₩92.73 Billion ≈ $62.84 Million |
-45.87pp |
| 2016-12-31 | 76.31% | ₩67.76 Billion ≈ $45.92 Million |
₩88.79 Billion ≈ $60.17 Million |
+73.86pp |
| 2015-12-31 | 2.45% | ₩855.00 Million ≈ $579.42K |
₩34.93 Billion ≈ $23.67 Million |
+2.07pp |
| 2014-12-31 | 0.38% | ₩95.00 Million ≈ $64.38K |
₩25.17 Billion ≈ $17.06 Million |
-- |
About NDFOS Co. Ltd
NDFOS Co., Ltd. operates as a tape and film company in South Korea. The company offers adhesive tapes, such as waterproof tapes, light-shielding tapes, heat reaction tapes, battery fixing tapes, thin film tapes, convergence type functional tapes, and heat radiation tapes; functional films, including automobiles, industries, and everyday life. It also develops ARS and STR, anticancer drugs for can… Read more